Publications by authors named "Behjat Moayedi"

Claim this Profile
T
Therapeutic potential of silymarin as a natural iron-chelating agent in β-thalassemia intermedia.
Nahid Reisi, Nafiseh Esmaeil, Marjan Gharagozloo, Behjat Moayedi

Clin Case Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant immunomodulatory and hepatoprotective impacts of Silymarin in MS patients: A double-blind placebo-controlled clinicaltrial.
Faezeh Abbasirad, Vahid Shaygannejad, Fahimeh Hosseininasab, Omid Mirmosayyeb, Behzad Mahaki, Behjat Moayedi

Int Immunopharmacol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silymarin impacts on immune system as an immunomodulator: One key for many locks.
Nafiseh Esmaeil, Sima Balouchi Anaraki, Marjan Gharagozloo, Behjat Moayedi

Int Immunopharmacol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation of Immunotoxin Herceptin-Botulinum and Killing Effects on Two Breast Cancer Cell Lines.
Saieh Hajighasemlou, Mahmoud Alebouyeh, Hossein Rastegar, Mojgan Taghizadeh Manzari, Milad Mirmoghtadaei, Behjat Moayedi

Asian Pac J Cancer Prev· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum levels of TGFβ, IL-10, IL-17, and IL-23 cytokines in β-thalassemia major patients: the impact of silymarin therapy.
Sima Balouchi, Marjan Gharagozloo, Nafiseh Esmaeil, Milad Mirmoghtadaei, Behjat Moayedi

Immunopharmacol Immunotoxicol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated serum levels of cell death circulating biomarkers, M30 and M65, in patients with β-thalassemia major.
Nafiseh Esmaeil, Behjat Moayedi, Marjan Gharagozloo, Mohamad Reza Maracy

Hemoglobin· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine.
Behjat Moayedi, Marjan Gharagozloo, Nafiseh Esmaeil, Mohammad R Maracy, Hamid Hoorfar

Eur J Haematol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
Marjan Gharagozloo, Behjat Moayedi, Maryam Zakerinia, Mehrdad Hamidi, Mehran Karimi

Fundam Clin Pharmacol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Influence of Iron Loading and Iron Chelation on the Proliferation and Telomerase Activity of Human Peripheral Blood Mononuclear Cells.
Bahram Bagherpour, Marjan Gharagozloo, Behjat Moayedi

Iran J Immunol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Premature senescence of T lymphocytes from patients with beta-thalassemia major.
Marjan Gharagozloo, Bahram Bagherpour, Mahmoud Tahanian, Farzad Oreizy, Zahra Amirghofran, Behjat Moayedi

Immunol Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of silymarin on the proliferation and glutathione levels of peripheral blood mononuclear cells from beta-thalassemia major patients.
Fariba Alidoost, Marjan Gharagozloo, Bahram Bagherpour, Abbas Jafarian, Seyed Ebrahim Sajjadi, Behjat Moayedi

Int Immunopharmacol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis